Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042048 · ClinicalTrials.gov registry record · NA
Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization
A NA study, sponsored by The Cooper Health System.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07042048: Clinical Trial NA study, sponsored by The Cooper Health System.
NCT07042048 is a NA study that has not yet begun recruiting, run by The Cooper Health System. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042048, a NA study, has not yet begun recruiting, sponsored by The Cooper Health System.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patients needing an EVD for spontaneous ICH with IVH or severe TBI. The main question it aims to answer is: Can EVDs be placed successfully with at least equal safety and efficacy using augmented reality devices in comparison to using standard image-guidance techniques?
Primary Outcome
Post-procedural non-contrast head CT will be reviewed by masked assessor to evaluate success of EVD placement per the Kakarla grading system. This grading system classifies catheter positioning into three grades based on postoperative imaging. Grade 1 indicates optimal placement in the ipsilateral frontal horn or third ventricle for effective drainage. Grade 2 represents functional but non-ideal placement in the contralateral ventricle or non-eloquent cortex. Grade 3 denotes suboptimal placement
Interventions
- DEVICE EVD placement - image-guidance assisted
- DEVICE EVD placement - AR assisted
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What is known before NCT07042048 opens enrollment
NCT07042048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which EVD placement - image-guidance assisted is the first listed.
NCT07042048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07042048 about?
NCT07042048 is a clinical study titled "Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization". The goal of this clinical trial is to assess if EVD placement using augmented reality is non inferior to image-guidance systems for assistance in adult patients needing an EVD for spontaneous ICH with IVH or severe TBI. The main question it aims to answer is: Can EVDs be placed successfully with at...
What is the current status of trial NCT07042048?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-07-01. Estimated completion is 2026-03-31.
What interventions are being tested in trial NCT07042048?
The interventions under investigation include: EVD placement - image-guidance assisted (DEVICE), EVD placement - AR assisted (DEVICE).
Who is sponsoring clinical trial NCT07042048?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07042048's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI